ABL Bio Inc. sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier penetrating bispecific antibody platform, ...

Gov. Josh Shapiro announced in October GSK’s $800 million project that is expected to create at least 200 new jobs and retain ...

Aston Martins and Scotch whisky are likely to become more expensive in the US under Donald Trump. Car manufacturing and the ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

See reviews below to learn more or submit your own review. ProAir HFA Inhalers provides respiratory relief of bronchospasm and wheezing through metered-dose inhalers. Developed for asthma and COPD ...

has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications. British pharmaceutical company GSK ...

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical ...